1. Antihistamine activity and central effects of WAL 801 CL in man;Adamus;Eur. J. Clin. Pharmacol.,1987
2. Pharmacodynamics of the new H1-antagonist 3-amino-9,13b-dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepine hydrochloride in volunteers;Adamus;Arzneimittelforschung,1987
3. Substance P inducetion of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice;Andoh;J. Pharmacol. Exp. Med.,1998
4. Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators;Awouters;Experientia,1977
5. Treatment of atopic dermatitis with oxatomide oral suspension (2.5 mg/ml) in infants;Bergonizi;Minerva Pediatr.,1997